These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 24237023)
1. The ITC as an attractive patent litigation forum for the biotechnology and pharmaceutical industry. Burton CA; Margonis LE Pharm Pat Anal; 2013 Mar; 2(2):177-80. PubMed ID: 24237023 [No Abstract] [Full Text] [Related]
2. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape. Lu DL; Kowalski TJ; Jarecki-Black J Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040 [No Abstract] [Full Text] [Related]
3. Patent fight sparks biological warfare in the drug industry. Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662 [No Abstract] [Full Text] [Related]
4. Patent watch: Progress in three key patent disputes in 2009. Nat Rev Drug Discov; 2010 Jan; 9(1):12-3. PubMed ID: 20050395 [No Abstract] [Full Text] [Related]
5. Pharmaceutical patent life-cycle management after KSR v. Teleflex. Furrow ME Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462 [No Abstract] [Full Text] [Related]
6. Proposed changes to patent code loom over biotech industry. Coombs A Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010 [No Abstract] [Full Text] [Related]
9. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech. Garber K Science; 2006 May; 312(5775):827. PubMed ID: 16690824 [No Abstract] [Full Text] [Related]
10. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents. Teitelbaum R; Cohen M Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990 [No Abstract] [Full Text] [Related]
13. Biotech patents-business as usual? Lawrence S Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861 [No Abstract] [Full Text] [Related]
14. Enforcing pharmaceutical and biotech patent rights in China. Zhang YP; Deng MM Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760 [No Abstract] [Full Text] [Related]
15. Innovators working hard to avoid patent exclusions in the US. Tombling A Drug Discov Today; 2013 Dec; 18(23-24):1131-2. PubMed ID: 24120891 [No Abstract] [Full Text] [Related]
17. Compulsory licenses as a defense in pharmaceutical and biotech patent litigation. von Falck A Pharm Pat Anal; 2016 Sep; 5(6):351-353. PubMed ID: 27805479 [No Abstract] [Full Text] [Related]
18. The application of the patent laws to the drug approval process. Coggio BD; Cerrito FD Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669 [No Abstract] [Full Text] [Related]
19. Robert Stoll. Interview by Charlotte Harrison. Stoll R Nat Rev Drug Discov; 2009 Dec; 8(12):926. PubMed ID: 19949397 [No Abstract] [Full Text] [Related]